期刊文献+

人类骨肉瘤中P53、Bcl-2、Bax蛋白的表达和临床特征 被引量:3

Expression and clinical significance of P53.Bcl-2 and Bax protein in human osteosarcoma
下载PDF
导出
摘要 目的研究P53、Bcl-2和Bax蛋白在骨肉瘤中的表达情况,探讨P53、Bcl-2和Bax基因在骨肉瘤发生和发展中的作用,研究三者在骨肉瘤中的表达与骨肉瘤组织学分级之间的关系.方法采用S-P免疫组化方法观察42例骨肉瘤中P53蛋白、Bcl-2蛋白和Bax蛋白的表达情况.结果 1.在骨肉瘤中P53蛋白、Bcl-2蛋白和Bax蛋白的阳性率分别为61.9%、66.7%、61.9%.2.骨肉瘤Ⅰ~Ⅲ级中P53蛋白阳性率分别为41.7%、53.3%、85.7%,在Ⅰ级与Ⅲ级之间存在显著性差异(P<0.05).3.骨肉瘤Ⅰ~Ⅲ级中Bcl-2蛋白阳性率分别为41.7%、62.5%、92.9%.在Ⅱ级与Ⅲ级之间存在显著性差异(P<0.05),在Ⅰ级与Ⅲ级之间存在显著性差异(P<0.01).Bax蛋白阳性率在各级间无显著性差异(P>0.05).4.在骨肉瘤P53蛋白表达阴性组中Bcl-2蛋白的阳性率显著低于P53蛋白表达阳性组(P<0.01).5.在骨肉瘤Bcl-2蛋白表达阴性组中Bax蛋白的阳性率显著低于Bcl-2蛋白表达阳性组(P<0.05).结论利用S-P免疫组化法检测骨肉瘤中P53、Bcl-2和Bax蛋白的表达具有较高的敏感性及临床实用价值. ve To study the expression of P53, Bcl-2 and Bax protein in osteosarcoma, and dis-cuss the function of P53,Bcl-2 and Bax gene in the occurrence and development of human osteosarcomas.to study the relation between the expression of the three proteins and the pathological classification in osteosarco-mas. Methods 42 cases of osteosarcoma have been examined with the method of S-P immunohistochemistry. Results 1.The expression rate of P53, Bcl-2 and Bax protein in osteosarcoma was respectively 61.9%, 66.7% and 61.9% .2.The expression rate of P53 protein in osteosarcoma grade Ⅲ was higher than that in osteosarcoma grade I (P<0.05).3.The expression rate of Bcl-2 protein in osteosarcoma grade Ⅲ was higher than that in osteosarcoma grade I (P<0.01) ,but the expression rate of Bax protein had no significant dif-ference(P>0.05).4.The expression rate of Bcl-2 protein in cases with negative P53 protein expression was lower than that in cases with positive P53 protein expression(P<0.01).5.The expression rate of Bax protein in cases with negative Bcl-2 protein expression was lower than that in cases with positive Bcl-2 protein expres-sion(P<0.05).Conclusion Expression of P53,Bcl-2 protein is related to the pathological classification and can reflect the malignant degree of osteosarcoma. S-P imrnunohistochernistry method has a higher sensitivity and clinical value.
出处 《中国骨伤》 CAS 2002年第4期214-216,共3页 China Journal of Orthopaedics and Traumatology
关键词 骨肿瘤 免疫组织化学 蛋白 P53 BCL-2 BAX Bone tumor Immunohistochemistry Protein
  • 相关文献

参考文献2

  • 1Price CHG.The prognosis of osteosarcoma[].British Journal of Radiology.1996
  • 2Hanada M,Aime-Sempe C,Sato T,et al.Structure-function analysis ofBcl-2 protein[].Journal of Biological Chemistry.1995

同被引文献48

  • 1王敏,吕智.凋亡调控基因Bcl-2、Bax、Caspase-3与骨肉瘤[J].实用骨科杂志,2005,11(3):233-236. 被引量:7
  • 2高大新,张海燕,吕刚,李永军,黄涛,王岩峰.Survivin反义寡核苷酸联合顺铂治疗裸鼠荷骨肉瘤[J].中华实验外科杂志,2005,22(8):1003-1004. 被引量:9
  • 3余晓林,刘红,陈万平,程鹏远.GFP共表达的重构型Caspase-3基因对Hep-2细胞的作用[J].第四军医大学学报,2005,26(21):1945-1947. 被引量:3
  • 4黄涛,吕刚,李建华,孙洁,王岩峰,顾海伦,段有文,高大新.Fas在骨肉瘤中的表达及其意义[J].中国医科大学学报,2006,35(1):89-89. 被引量:1
  • 5T. Nedelcu,B. Kubista,A. Koller,I. Sulzbacher,I. Mosberger,F. Arrich,K. Trieb,R. Kotz,C. D. Toma.Livin and Bcl-2 expression in high-grade osteosarcoma[J]. Journal of Cancer Research and Clinical Oncology . 2008 (2)
  • 6Bharti AC,Aggarwal BB.Nuclear factor-kappa B and cancer: its role in prevention and therapy. Biochemical Pharmacology . 2002
  • 7Ferrari S,Bertoni F,Zanella L,et al.Evaluation of P-glycoprotein, HER-2/ErbB-2, p53, and Bcl-2 in primary tumor and metachronous lung metastases in patients with high-grade osteosarcoma. Cancer . 2004
  • 8Deveraux QL,Reed JC.IAP family proteins-suppressors of apoptosis. Genes and Development . 1999
  • 9Trieb K,Lehner R,Stulnig T,et al.Survivin expression in human osteosarcoma is a marker for survival. European Journal of Surgical Oncology . 2003
  • 10Fesik S W.Promoting apoptosis as a strategy for cancer drug discov-ery. Nature Reviews Cancer . 2005

引证文献3

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部